Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Free Cash Flow (2019 - 2025)

Historic Free Cash Flow for IDEAYA Biosciences (IDYA) over the last 7 years, with Q3 2025 value amounting to $142.2 million.

  • IDEAYA Biosciences' Free Cash Flow rose 38611.22% to $142.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$105.4 million, marking a year-over-year increase of 3123.64%. This contributed to the annual value of -$251.4 million for FY2024, which is 11382.49% down from last year.
  • According to the latest figures from Q3 2025, IDEAYA Biosciences' Free Cash Flow is $142.2 million, which was up 38611.22% from -$63.1 million recorded in Q2 2025.
  • IDEAYA Biosciences' Free Cash Flow's 5-year high stood at $142.2 million during Q3 2025, with a 5-year trough of -$122.8 million in Q4 2024.
  • Its 5-year average for Free Cash Flow is -$26.4 million, with a median of -$25.3 million in 2022.
  • Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 39929.63% in 2024, then skyrocketed by 38611.22% in 2025.
  • Over the past 5 years, IDEAYA Biosciences' Free Cash Flow (Quarter) stood at -$17.3 million in 2021, then plummeted by 35.38% to -$23.4 million in 2022, then dropped by 5.2% to -$24.6 million in 2023, then tumbled by 399.3% to -$122.8 million in 2024, then skyrocketed by 215.82% to $142.2 million in 2025.
  • Its last three reported values are $142.2 million in Q3 2025, -$63.1 million for Q2 2025, and -$61.7 million during Q1 2025.